GlaxoSmithKline compound 6i [PMID:18926700] [3688]
GlaxoSmithKline compound 6i [PMID:18926700]
| SMILES |
CC[C@@H]1[C@@H](C)[C@H](Nc2ccccc2)c2ccccc2N1C(=O)c1cc(Cl)cc(Cl)c1 |
| InChIKey |
DKLLTFTXYHJXHK-OAEOJWKDSA-N |
Chemical Properties
| Hydrogen bond acceptors |
2 |
| Hydrogen bond donors |
1 |
| Rotatable bonds |
4 |
| Log P |
7.222 |
| Molecular weight (Da) |
438.1 |
| Stereochemistry info |
full |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
GlaxoSmithKline compound 6i [PMID:18926700]
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.